Carisma Therapeutics Inc share price logo

Carisma Therapeutics Inc Share Price

NASDAQ: CARM

$0.04

-0.01

(-20.13%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 13 Oct 2025

Carisma Therapeutics Inc Stock Performance

as on October 24, 2025 at 1:28 am IST

  • Day's Low

    Day's High

    $0.03
    $0.05
    downward going graph

    25.00%

    Downside

    25.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.05
    $1.27
    downward going graph

    -13.00%

    Downside

    3075.00%

    Upside

    downward going graph

Carisma Therapeutics Inc share price movements today

Previous Close
$0.05
Open
$0.05
Volume
5.3M
Day's Low - High
$0.03 - $0.05
52 Week Low - High
$0.05 - $1.27

Carisma Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Carisma Therapeutics Inc Stock Fundamentals & Key Indicators

Check Carisma Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Carisma Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Carisma Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$60.9B251.94%-505.15-12.96%
NA$35.9BNANA-3.89%
BUY$109.3B99.75%30.3131.86%
BUY$62.0B-0.71%14.7331.37%

Analyst Recommendation on Carisma Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Carisma Therapeutics Inc. Average target price of $1

Carisma Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Carisma Therapeutics Inc.

What analysts predicted

96%UPSIDE

Target Price

$1

Current Price

$0.04

Analyzed by

12 Analysts

Target

$1.00

Carisma Therapeutics Inc target price $1, a slight upside of 96% compared to current price of $0.04. According to 12 analysts rating.

Carisma Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Carisma Therapeutics Inc Shares on INDmoney has dropped by -40.87% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-40.87% versus previous 30 day period

Carisma Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
3
3
4
3
9
3
3
3
-
Gross Profit
2
2
3
-
1
8
3
2
3
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-24
-19
-21
-20
-18
-11
-12
-17
-9
-9
Net Profit Margin
-759.85%
-558.31%
-559.26%
-488.65%
-558.67%
-121.37%
-375.24%
-482.75%
-248.48%
0.00%

Carisma Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
29
0
11
26
9
14
19
Gross Profit
0
29
0
11
26
3
-59
-40
Operating Income
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-33
1
-29
-28
-40
-61
-86
-60
Net Profit Margin
-3378.99%
6.31%
-6830.35%
-252.31%
-153.65%
-622.60%
-582.34%
-308.05%

Insights on Carisma Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.38M → 3.72M (in $), with an average increase of 4.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 157.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CARM stock has moved down by -83.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -9.26M → -9.77M (in $), with an average decrease of 5.5% per quarter

About Carisma Therapeutics Inc

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on macrophage engineering to develop transformative therapies to treat serious diseases including liver fibrosis and cancer. The Company seeks to apply the ability to engineer macrophages and monocytes, either in vivo or ex vivo. Its proprietary chimeric antigen receptor macrophages(CAR-M) platform uses CARs to redirect macrophages or monocytes against specific tumor associated antigens with the goal of targeted antitumor immunity. It is developing a pipeline of product candidates which includes CT-1119, In Vivo CAR-Macrophage: GPC3+ Solid Tumors, In Vivo CAR-Macrophage: Oncology Targets, and CT-2401 (Liver Fibrosis). CT-2401 is a product candidate in development for liver fibrosis, and CT-1119 is a mesothelin-targeted CAR-Monocyte that is designed to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others.
OrganisationCarisma Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Carisma Therapeutics Inc share price today?

Carisma Therapeutics Inc share price today is $0.04 as on at the close of the market. Carisma Therapeutics Inc share today touched a day high of $0.05 and a low of $0.03.

What is the 52 week high and 52 week low for Carisma Therapeutics Inc share?

Carisma Therapeutics Inc share touched a 52 week high of $1.27 on and a 52 week low of $0.05 on . Carisma Therapeutics Inc stock price today i.e. is closed at $0.04,which is 96.85% down from its 52 week high and -11.50% up from its 52 week low.

How to invest in Carisma Therapeutics Inc Stock (CARM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Carisma Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Carisma Therapeutics Inc Shares that will get you 37.5000 shares as per Carisma Therapeutics Inc share price of $0.04 per share as on October 24, 2025 at 1:28 am IST.

What is the minimum amount required to buy Carisma Therapeutics Inc Stock (CARM) from India?

Indian investors can start investing in Carisma Therapeutics Inc (CARM) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Carisma Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Carisma Therapeutics Inc share’s latest price of $0.04 as on October 24, 2025 at 1:28 am IST, you will get 250.0000 shares of Carisma Therapeutics Inc. Learn more about fractional shares .